Rhino-orbital-cerebral mucormycosis has emerged as an epidemic within the COVID-19 pandemic. Its treatment requires a multi-disciplinary approach and, therefore, there is a need for consensus among clinicians for a common management protocol. Orbis along with Dr Shroff’s Charity Eye Hospital, New Delhi, brought forth a special lecture which included experts from both the Orbis partner hospital and a renowned Indian multispecialty healthcare facility, Sir Ganga Ram Hospital.
Designed to provide a common platform for doctors from varied disciplines grappling with the commonly known 'black fungus', the lecture enabled experts from India to share their knowledge in the management of the condition and deliberate on a common treatment protocol.
Dr Rishi Raj Borah, Country Director observed the rare occurrence that mucormycosis must be managed by not one but several specialists of whom an ophthalmologist plays a key role. The need came into light when Orbis’s partners in India also found impact of the emerging epidemic.
The webinar brought together an ophthalmologist, radiologist, otolaryngologist, an intensivist, and a microbiologist from India battling with the common challenge. It was clear- mucormycosis needed a multi-disciplinary approach. Each of the experts described the need and perspective of their specialties to bring positive patient outcome to light.
